Showing results (31-40 of 742) with videos related to
Sort By:
Pageof 75
Social Psychiatry and Psychiatric Epidemiology|May 1, 1992
A psychiatric unit in a general hospital in Brazil: predictors of length of stayP Dalgalarrondo, W F GattazPsychiatry Research|September 29, 1995
Intracerebroventricular injection of phospholipase A2 inhibits apomorphine-induced locomotion in ratsJ Brunner, W F GattazProstaglandins, Leukotrienes, and Essential Fatty Acids|August 1, 1996
Phospholipase A2 and the hypofrontality hypothesis of schizophreniaW F Gattaz, J BrunnerBiological Psychiatry|November 15, 1993
Pain perception threshold in major depressionG Adler, W F GattazEuropean Archives of Psychiatry and Clinical Neuroscience|January 1, 1994
Basal ganglia abnormalities in tardive dyskinesia. Possible relationship with duration of neuroleptic treatmentP Dalgalarrondo, W F GattazJournal of Neural Transmission (Vienna, Austria : 1996)|October 27, 2006
Requirement of hippocampal phospholipase A2 activity for long-term memory retrieval in ratsE L Schaeffer, W F GattazThe Journal of Neuropsychiatry and Clinical Neurosciences|January 1, 1989
Neurotensin-like immunoreactivity in cerebrospinal fluid of patients with schizophrenia, depression, anorexia nervosa-bulimia, and premenstrual syndromeC B Nemeroff, G Bissette, E Widerlov, et al.Journal of Neural Transmission. General Section|January 1, 1993
Vitamin E attenuates the development of haloperidol-induced dopaminergic hypersensitivity in rats: possible implications for tardive dyskinesiaW F Gattaz, A Emrich, S BehrensArquivos De Neuro-Psiquiatria|September 1, 1988
[Cerebral computed tomography and schizophrenia: a critical review of the literature]C Von Krakauer Hübner, W F GattazSchizophrenia Research|July 1, 1995
Increased platelet phospholipase A2 activity in schizophreniaW F Gattaz, A Schmitt, A MarasPageof 75